Cargando…

Clinical Significance of CK19 Negative Breast Cancer

Analysis of sentinel lymph nodes (SLNs) by means of One-Step Nucleic Acid Amplification (OSNA) is gaining widespread use as a quick and accurate method. This assay detects the expression level of cytokeratin 19 (CK19) which is present in some but not all breast tumors. In this study, the clinical si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujisue, Mamiko, Nishimura, Reiki, Okumura, Yasuhiro, Tashima, Rumiko, Nishiyama, Yasuyuki, Osako, Tomofumi, Toyozumi, Yasuo, Arima, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730313/ https://www.ncbi.nlm.nih.gov/pubmed/24216695 http://dx.doi.org/10.3390/cancers5010001

Ejemplares similares

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index
por: Arima, Nobuyuki, et al.
Publicado: (2016)

Evaluation of an Optimal Cut-Off Point for the Ki-67 Index as a Prognostic Factor in Primary Breast Cancer: A Retrospective Study
por: Tashima, Rumiko, et al.
Publicado: (2015)

Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis
por: Nishimura, Reiki, et al.
Publicado: (2011)

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan
por: OSAKO, TOMOFUMI, et al.
Publicado: (2015)

An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2017)

BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer
por: Mori, Hitomi, et al.
Publicado: (2016)

Microsatellite instability in Japanese female patients with triple-negative breast cancer
por: Kurata, Kanako, et al.
Publicado: (2020)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer
por: Mizoguchi, Kimihisa, et al.
Publicado: (2023)

CK 20‐positive and CK 7‐negative Merkel cell carcinoma of the cheek
por: Rai, Manoj Ponadka, et al.
Publicado: (2018)

Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer
por: Sood, Neelam, et al.
Publicado: (2014)

CK-7 negative primary lung adenocarcinoma
por: Tchienga, Dimitri, et al.
Publicado: (2023)

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
por: Adamo, Barbara, et al.
Publicado: (2017)

Macro-CK and CK-BB Contributing to Sham CK-MB Elevation
por: Wada, Yuki, et al.
Publicado: (2017)

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
por: Adamo, Barbara, et al.
Publicado: (2019)

Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
por: Wang, Zhen, et al.
Publicado: (2021)

Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer
por: Court, Alice, et al.
Publicado: (2022)

Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins
por: Shimizu, Naoko, et al.
Publicado: (2021)

Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women
por: Kanapathy Pillai, Shant Kishen, et al.
Publicado: (2012)

Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma
por: Boricic, Novica, et al.
Publicado: (2022)

Comparing the Diagnostic Outcomes of Staining Various Breast Lesions with Either Anti-CK 5/6 or Anti-CK 5
por: Gudi, Mihir A, et al.
Publicado: (2019)

An Immunohistochemical Expression of CK5/6, CK7, and CK20 on Cell Blocks in Metastatic Cervical Lymphadenopathy
por: Kaur, Amanpreet, et al.
Publicado: (2022)

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17
por: Khilko, Natalya, et al.
Publicado: (2010)

Dominant-Negative CK2α Induces Potent Effects on Circadian Rhythmicity
por: Smith, Elaine M, et al.
Publicado: (2008)

The Multiple Personalities of the Regulatory Subunit of Protein Kinase CK2: CK2 Dependent and CK2 Independent Roles Reveal a Secret Identity for CK2β
por: Bibby, Ashley C., et al.
Publicado: (2005)

A novel 1-bp deletion variant in DAG1 in Japanese familial asymptomatic hyper-CK-emia
por: Fan, Luoming, et al.
Publicado: (2022)

CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
por: Baier, Andrea, et al.
Publicado: (2022)

The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131
por: Vilardell, Jordi, et al.
Publicado: (2018)

dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer
por: Hu, Qiangsheng, et al.
Publicado: (2018)

Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast
por: Maeda, Ichiro, et al.
Publicado: (2018)

ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases
por: Joensuu, Kristiina, et al.
Publicado: (2013)

Coronary arterial microfistulae with meandering dilated coronary arteries and noncompaction-like myocardium
por: Yuki, Hideaki, et al.
Publicado: (2019)

Quantitative CK19 biomarker detection in breast cancer cell lines
por: Orafa, Zahra, et al.
Publicado: (2022)

Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021)

CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective
por: Akhtar, Mohammed, et al.
Publicado: (2020)

Does Photobiomodulation Affects CK10 and CK14 in Oral Mucositis Radioinduced Repair?
por: Sardo, Ariane Venzon Naia, et al.
Publicado: (2022)

CK2: channel controller
por: Williams, Ruth
Publicado: (2008)

Mining CK2 in Cancer
por: Ortega, Charina E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b1ib5mtionouv33cigm36omj22